About Champions Oncology, Inc.
https://www.championsoncology.comChampions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice.
CEO
Ronnie Morris
Compensation Summary
(Year 2025)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2015-08-12 | Reverse | 1:12 |
ETFs Holding This Stock
Summary
Showing Top 3 of 15
Ratings Snapshot
Rating : B-
Most Recent Analyst Grades
Grade Summary
Showing Top 1 of 1
Price Target
Institutional Ownership
BATTERY MANAGEMENT CORP.
Shares:2.42M
Value:$17.39M
BATTERY PARTNERS IX, LLC
Shares:2.42M
Value:$17.39M
NEA MANAGEMENT COMPANY, LLC
Shares:1.71M
Value:$12.3M
Summary
Showing Top 3 of 36
About Champions Oncology, Inc.
https://www.championsoncology.comChampions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q2-2026 | $15.04M ▲ | $7.23M ▲ | $299K ▲ | 1.99% ▲ | $0.02 ▲ | $612K ▲ |
| Q1-2026 | $13.99M ▲ | $6.15M ▼ | $-436K ▲ | -3.12% ▲ | $-0.03 ▲ | $-94K ▲ |
| Q4-2025 | $12.36M ▼ | $6.4M ▲ | $-1.83M ▼ | -14.84% ▼ | $-0.13 ▼ | $-1.57M ▼ |
| Q3-2025 | $17.04M ▲ | $5.53M ▲ | $4.5M ▲ | 26.38% ▲ | $0.33 ▲ | $4.92M ▲ |
| Q2-2025 | $13.49M | $4.93M | $728K | 5.4% | $0.05 | $1.14M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q2-2026 | $8.52M ▼ | $30.16M ▼ | $25.93M ▼ | $4.17M ▲ |
| Q1-2026 | $10.32M ▲ | $30.55M ▼ | $27.01M ▼ | $3.51M ▼ |
| Q4-2025 | $9.79M ▲ | $32.34M ▲ | $28.57M ▲ | $3.77M ▼ |
| Q3-2025 | $3.2M ▲ | $30.63M ▲ | $25.16M ▲ | $5.47M ▲ |
| Q2-2025 | $2.75M | $25.24M | $24.56M | $681K |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q2-2026 | $236K ▲ | $-1.74M ▼ | $-242K ▼ | $168K ▲ | $-1.81M ▼ | $-1.98M ▼ |
| Q1-2026 | $-466K ▲ | $600K ▼ | $-46K ▲ | $-14K ▲ | $540K ▼ | $554K ▼ |
| Q4-2025 | $-1.83M ▼ | $6.87M ▲ | $-253K ▼ | $-32K ▼ | $6.58M ▲ | $6.62M ▲ |
| Q3-2025 | $4.5M ▲ | $490K ▲ | $-42K ▲ | $0 ▼ | $448K ▲ | $448K ▲ |
| Q2-2025 | $728K | $-283K | $-94K | $239K | $-138K | $-377K |
Revenue by Products
| Product | Q2-2025 | Q4-2025 | Q3-2025 | Q1-2026 |
|---|---|---|---|---|
 Pharmacology Services | $10.00M ▲ | $10.00M ▲ | $10.00M ▲ | $10.00M ▲ |
 Product and Service Other | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
CEO
Ronnie Morris
Compensation Summary
(Year 2025)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2015-08-12 | Reverse | 1:12 |
ETFs Holding This Stock
Summary
Showing Top 3 of 15
Ratings Snapshot
Rating : B-
Most Recent Analyst Grades
Grade Summary
Showing Top 1 of 1
Price Target
Institutional Ownership
BATTERY MANAGEMENT CORP.
Shares:2.42M
Value:$17.39M
BATTERY PARTNERS IX, LLC
Shares:2.42M
Value:$17.39M
NEA MANAGEMENT COMPANY, LLC
Shares:1.71M
Value:$12.3M
Summary
Showing Top 3 of 36